Morgan Stanley Agile Therapeutics Inc Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.21 - $0.31 $10 - $15	-49 Reduced 2.09%	2,299 $0
Q4 2022 Feb 14, 2023	SELL	$0.18 - $15.25 $384 - $32,604	-2,138 Reduced 47.66%	2,348 $0
Q3 2022 Nov 14, 2022	BUY	$0.28 - $14.85 $692 - $36,709	2,472 Added 122.74%	4,486 $1,000
Q2 2022 Aug 15, 2022	BUY	$1.09 - $8.24 $2,195 - $16,595	2,014 New	2,014 $2,000

Ticker AGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 39,023,000
Description
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.